the treatment of hypertension. Irbesartan was developed by Sanofi Research drug research avapro part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under the trade names to irbesartan preparations, including CoAprovel, Karvezide, Avalide and Avapro HCT.[edit] References^.

due to type 2 diabetes.". N Engl J Med 345 (12): 851-60. PMID 11565517.^ drug research avapro S, editor. Australian drug research avapro Handbook drug research avapro Adelaide: Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN drug research avapro IrbesartanFrom Wikipedia, the free encyclopedia(Redirected from Avapro)Jump drug research avapro navigation, searchIrbesartanSystematic (IUPAC) name2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-oneIdentifiersCAS number 138402-11-6ATC code C09CA04PubChem 3749DrugBank APRD00413Chemical dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability 60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonists, irbesartan is indicated for the reduction of renal disease drug research avapro renal.

Raz I; Collaborative Study Group. (2001). "Renoprotective effect of the angiotensin-receptor antagonist.